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Introduction {#sec006}
============

Adipose tissue is a specialized, loose connective tissue laden with adipocytes and sometimes stored in ectopic locations, such as near muscle, liver, the heart, and within the abdominal cavity \[[@pone.0231156.ref001]\]. Adipose tissue usually infiltrates within or around the muscle fibers, with adipose tissue infiltration "within" the muscle referred to as intramuscular adipose tissue or "IntraMAT" \[[@pone.0231156.ref001]\]. IntraMAT is an important measure in research, and in older individuals and patients with Duchenne muscular dystrophy, IntraMAT is inversely associated with insulin resistance \[[@pone.0231156.ref002]--[@pone.0231156.ref005]\], force generation \[[@pone.0231156.ref006]--[@pone.0231156.ref009]\], and a range of functional ability tests (e.g., 6-minute walk distance \[[@pone.0231156.ref008], [@pone.0231156.ref010]\], gait speed \[[@pone.0231156.ref011], [@pone.0231156.ref012]\], sit-to-stand \[[@pone.0231156.ref011], [@pone.0231156.ref012]\], stair descent time \[[@pone.0231156.ref008], [@pone.0231156.ref012]\], and timed up and go tests \[[@pone.0231156.ref012]\]). Furthermore, studies show that IntraMAT values of the lower limb muscles, such as the thigh muscles, increase with age \[[@pone.0231156.ref006]--[@pone.0231156.ref009]\]. IntraMAT values therefore aid in our understanding of insulin resistance, muscle functional ability, and muscle quality and could be used to create thresholds that identify patients who may be at risk of developing type 2 diabetes in the future. The values could also help in identifying patients with early myopathy as a window into muscular dystrophy, for example.

Magnetic resonance imaging (MRI) is a powerful tool to assess the quality and quantity of human skeletal muscles, and to investigate the IntraMAT of target muscles, T1-weighted (T1W) imaging and the Dixon method have been frequently used in previous studies. IntraMAT has been calculated based on T1W images combined with segmentation analysis in previous studies \[[@pone.0231156.ref012]--[@pone.0231156.ref016]\]. The Dixon method is an alternate, relatively inventive technique for the evaluation of fat fractions based on the different precessional frequencies of water and lipid protons \[[@pone.0231156.ref017]--[@pone.0231156.ref019]\]. Previous studies confirmed that IntraMAT content by both the T1W and Dixon methods were consistent or correlated with muscle biopsy, which is the gold standard to measure IntraMAT \[[@pone.0231156.ref020], [@pone.0231156.ref021]\]. The IntraMAT content in the thigh measured by the three-point Dixon (3PD) method was approximately 3% in younger men and 6% in older men \[[@pone.0231156.ref022]\]. Others have reported specific muscle values: 3.0% for younger and 5.4% for older men in the vastus lateralis (VL) and 3.9% for younger and 7.2% for older men in the biceps femoris-long head (BF-L) \[[@pone.0231156.ref022]\]. Recently, a study reported no significant difference (*P* = 0.83) between the fat fractions determined by two-point Dixon (2PD) and lipocytes assessed by histological analysis taken from muscle biopsies, indicating that the Dixon technique is reliable for the quantification of IntraMAT \[[@pone.0231156.ref020]\]. However, T1W imaging has been widely used for the diagnosis of diseases as well as in medical imaging research. Previous studies with T1W imaging have used histograms to separate skeletal muscle tissue and adipose tissue based on differences in pixel intensity, which mainly comes from differences in the spin-lattice relaxation times between skeletal muscle and adipose tissues, whereas others have used different muscle and adipose tissue threshold settings for discrimination \[[@pone.0231156.ref014], [@pone.0231156.ref015], [@pone.0231156.ref023]--[@pone.0231156.ref025]\]. We previously reported that IntraMAT content using T1W images is 4.6% in the VL and 16.2% in the BF-L in older subjects (70.7 ± 3.8 years) \[[@pone.0231156.ref014]\]. These values are slightly higher than those taken by 3PD images (0.8% for VL and 9% for BF-L) \[[@pone.0231156.ref020]\]. Several factors affect IntraMAT content between two imaging techniques, including subject characteristics, differences in spatial resolution, and differences in the sensitivity of the imaging apparatus to adipose tissues located inside and outside of the muscle cells.

The proportion of IntraMAT by 2PD is consistent with the results of histological evaluations from biopsy specimens \[[@pone.0231156.ref020]\], and a correlation between the proportion of IntraMAT by T1W and biopsy results has been reported \[[@pone.0231156.ref021]\]. It is therefore plausible that IntraMAT values of T1W and 2PD may match; yet, to the best of our knowledge, no study has tested the agreement between T1W imaging and Dixon imaging for IntraMAT content on the same subjects using the same locations. Thus, the purpose of this study was to compare IntraMAT content determined by 2PD imaging and T1W imaging, calculated using thresholding techniques. This study is useful for judging whether there is inconsistency in the IntraMAT contents by the two methods reported in previous studies. Those results are instrumental for selecting the imaging method used for diagnosis of IntraMAT in diseased patients. We hypothesized that IntraMAT values obtained with T1W would be slightly higher than those taken using 2PD.

Methods {#sec007}
=======

Subjects {#sec008}
--------

Nineteen younger men (26.2 ± 4.9 years, 22.2 ± 2.2 kg/m^2^) and 13 older men (72.2 ± 6.0 years, 23.9 ± 1.6 kg/m^2^) volunteered to participate in this study. Subjects were widely recruited healthy and non-obese (BMI \< 25.0 kg/m^2^) volunteers using a poster in the library. This experiment was conducted as a prospective study in 2016. Before the experiment, the procedure, purposes, risks, use data for research and benefits associated with the study were explained and written consent was obtained with all subjects. This study was approved by the Research Ethics Committee (Nagoya University; 2016--0254) and the investigation was performed according to the principles outlined in the Declaration of Helsinki.

MRI acquisition {#sec009}
---------------

Subjects were assessed with a 3.0 T whole-body MRI scanner (MAGNETOM Verio, Siemens Healthcare Diagnostics K.K., Tokyo, Japan). Subjects were placed in a supine position and images of the thigh were acquired using a body coil. We took consecutive images of the entire thigh using T1W and 2PD imaging. We defined the mid-thigh according to markers attached at the middle point between the greater trochanter and the lateral condyle of the femur. The durations for image acquisition were 4 min for the T1W and 8 min for the 2PD. T1W spin-echo transaxial images of the right thigh were collected with the following sequences: three-dimensional, TR = 604 ms; TE = 12 ms; flip angle = 120°; optimized field of view = 256 × 256 mm; slice thickness = 10 mm; and interslice gap = 0 mm. All subjects were instructed to remain as still as possible. In-phase and out-of-phase water and fat transaxial images were obtained to create water and fat images for analysis. 2PD images of the right thigh were acquired with the following sequences: three-dimensional, TR = 20 ms; TE1 = 2.450 ms; TE2 = 3.675 ms; flip angle = 9°; optimized field of view = 288 × 288 mm; slice thickness = 5 mm; and interslice gap = 0 mm.

We calculated the cross-sectional area (CSA) of the thigh in younger and older subjects from T1W and 2PD images to ensure that the same locations were being compared. As a result, CSAs of the thigh were not significantly different between T1W and 2PD values (T1W, 196.2 ± 30.7 cm^2^; 2PD, 195.3 ± 31.0 cm^2^). Therefore, we were able to measure the same area of the thigh using T1W and 2PD imaging ([Fig 1](#pone.0231156.g001){ref-type="fig"}).

![Representative T1-weighted (T1W) image (A) and 2-point Dixon (2PD) images of water (B) and fat (C).](pone.0231156.g001){#pone.0231156.g001}

Analysis of thigh composition {#sec010}
-----------------------------

MR images were read in random order for the analysis. We measured CSA of skeletal muscle and IntraMAT of the VL, adductor magnus (AM), and BF-L at the mid-thigh. Serial axial images were used to help identify muscle boundaries.

### 1) T1-weighted images {#sec011}

We used the Medical Image Processing, Analysis and Visualization software (version 4.4.0; National Institutes of Health, Bethesda, MD) to analyze images on a personal computer. The MRI data analysis procedure was essentially the same as described in previously studies \[[@pone.0231156.ref013]--[@pone.0231156.ref015]\]. Briefly, we first corrected for image heterogeneity caused by suboptimal radiofrequency coil uniformity, or gradient-driven eddy currents, using a well-established nonparametric nonuniform intensity normalization (N3) algorithm \[[@pone.0231156.ref014], [@pone.0231156.ref016], [@pone.0231156.ref026]\]. This step was essential for subsequent analyses that assume homogenous signal intensities across images. Optimized image correction parameters (N3) were determined (end tolerance, 0.0001; maximum iterations, 100; signal threshold, 1; field distance, 25 mm; subsampling factor, 4; Kernel full width, half maximum of 0.15; Wiener filter noise, 0.01), and the same parameters were applied to all images. Second, we calculated the CSA of IntraMAT content at the mid-thigh in T1W images using the threshold method, as described previously \[[@pone.0231156.ref014]\]. We then drew six regions of interest (ROIs) of 25 mm^2^ each, with three ROIs on the vastus intermedius and three ROIs on the subcutaneous adipose tissue. The vastus intermedius, which is 99% skeletal muscle \[[@pone.0231156.ref012]\], was chosen to obtain a pure skeletal muscle peak in the pixel number--signal intensity histogram. The total number of pixels within the six ROIs was used to produce a frequency distribution and histogram of all pixels and signal intensities.

To separate muscle and adipose tissues in the pixel number--signal intensity histogram with minimal investigator bias, we implemented the Otsu threshold method, a reliable histogram-shape--based thresholding technique used in medical imaging analysis \[[@pone.0231156.ref027]\]. To minimize manual tracing-induced errors on thresholding values, the mean of three trials was used, and the values were applied to the VL, AM, and BF-L. After carefully tracing the edge of each muscle, the following parameters were calculated: 1) the total number of pixels within the ROI; 2) the number of pixels with a signal intensity lower than the threshold value (skeletal muscle); and 3) the number of pixels with a value higher than the threshold value (IntraMAT). The IntraMAT content for each muscle was then calculated using the following equation:

![](pone.0231156.e001.jpg){#pone.0231156.e001g}
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### 2). Water and fat images by 2-point Dixon {#sec012}

Dixon images were analyzed using ImageJ (version 1.44; National Institutes of Health, Bethesda, MD, USA). ROIs were drawn to match the corresponding T1W image voxel locations for fat and water, calculated using the 3.5 ppm chemical shift between water and lipid at 3.0 T. From these VOIs, the mean signal intensities from water and fat images by 2PD were measured to create a Dixon-based fat--water ratio using the following equation \[[@pone.0231156.ref028]\]:
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### Reproducibility analysis {#sec013}

Manual segmentation of the thigh muscle compartments was repeated twice in 10 randomly selected subjects by one researcher with 5 years of experience in muscle image analysis to assess intra-observer reproducibility of the segmentation process. Intraclass correlation coefficient \[(ICC 2.1)\] in individual muscles indicated values ranging between 0.92 to 0.97 in T1W and 0.89 to 0.99 in 2PD for IntraMAT content (all *P* \< 0.001).

Statistical analysis {#sec014}
--------------------

IntraMAT content calculated by the two MRI methods were compared using Student's unpaired *t*-test. We compared IntraMAT content by the two MRI methods between the younger and the older men using Student's unpaired *t*-test. We estimated agreement using the 95% limits of agreement method developed by Bland and Altman \[[@pone.0231156.ref029]\], where the difference between the adipose tissue obtained with water and fat images by T1W and 2PD imaging is plotted against their means. The limits of agreement were between 1.96 SD and -1.96 SD. All continuous variables are expressed as the mean ± SD; a two-tailed *P* \< 0.05 was considered to indicate statistical significance. All statistical analyses were performed using IBM SPSS statistics (version 22.0; IBM, Tokyo, Japan).

Results {#sec015}
=======

[Table 1](#pone.0231156.t001){ref-type="table"} shows the IntraMAT content and range for the VL, AM, and BF-L. IntraMAT content in the VL determined by T1W imaging was not significantly different from that determined by 2PD; however, IntraMAT contents in the AM and BF-L were significantly higher with T1W than with 2PD imaging. In the older group, IntraMAT content was significantly higher than in the younger group in all muscles and with both the T1W and 2PD methods ([Table 1](#pone.0231156.t001){ref-type="table"}).

10.1371/journal.pone.0231156.t001

###### Effect of analysis order on intramuscular adipose tissue content (IntraMAT content; %) in T1W and 2PD images.

![](pone.0231156.t001){#pone.0231156.t001g}

                                              Mean ± SD                                           Younger group                                            Older group
  ------------------------------ ------------ --------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------
  **Vastus lateralis**           T1W          11.0 ± 4.4                                          8.9 (4.9--13.6)                                          14.1 (6.7--25.5) [†](#t001fn003){ref-type="table-fn"}
  2PD                            12.2 ± 2.4   10.9 (8.2--13.7)                                    14.0 (10.6--19.0) [†](#t001fn003){ref-type="table-fn"}   
  **Adductor magnus**            T1W          11.6 ± 4.4 [\*](#t001fn002){ref-type="table-fn"}    8.9 (4.5--17.1)                                          14.2 (9.4--24.3) [†](#t001fn003){ref-type="table-fn"}
  2PD                            8.6 ± 1.7    7.9 (6.4--9.8)                                      9.7 (7.1--14.1) [†](#t001fn003){ref-type="table-fn"}     
  **Biceps femoris-long head**   T1W          21.3 ± 10.0 [\*](#t001fn002){ref-type="table-fn"}   16.3 (6.5--27.5)                                         28.8 (5.6--45.3) [†](#t001fn003){ref-type="table-fn"}
  2PD                            12.7 ± 3.2   11.1 (7.1--14.2)                                    15.0 (9.9--21.1) [†](#t001fn003){ref-type="table-fn"}    

Abbreviations: T1W, T1-weighted; 2PD, 2-point Dixon.

\* vs. 2PD, *P* \< 0.05.

† vs. Younger group, *P* \< 0.05.

The relationship between IntraMAT content determined using T1W and 2PD is shown in 2. There was a high positive correlation between these two values using T1W and 2PD for the different muscles (VL; r = 0.735, *P* \< 0.01, AM; r = -0.717, *P* \< 0.01, BF-L; r = 0.790, *P* \< 0.01, VL + AM + BF-L; r = 0.686, *P* \< 0.01; [Fig 2](#pone.0231156.g002){ref-type="fig"}).

![Relationship between the intramuscular adipose tissue content (IntraMAT content; %) using T1-Weighted (T1W) and 2-Point Dixon (2PD) images in the Vastus Lateralis (VL), Adductor Magnus (AM), and the Biceps Femoris-Long head (BF-L).](pone.0231156.g002){#pone.0231156.g002}

[Fig 3](#pone.0231156.g003){ref-type="fig"} shows the Bland-Altman plot of IntraMAT content for each of the three muscles determined using the T1W and 2PD methods. The limits of agreement were between 1.96 SD and -1.96 SD. However, Bland-Altman plots showed that the Pearson r (difference versus mean) was -0.698 to -0.914 (*P* \< 0.01; [Fig 3](#pone.0231156.g003){ref-type="fig"}); therefore, a proportional bias was observed in all muscles ([Fig 3](#pone.0231156.g003){ref-type="fig"}). This suggests that subjects with higher IntraMAT contents showed larger differences between the two imaging modalities.

![Bland-Altman plots demonstrating the agreement for intramuscular adipose tissue content (IntraMAT content; %) of the Vastus Lateralis (VL), Adductor Magnus (AM) and the Biceps Femoris-Long head (BF-L) between T1-weighted and 2-Point Dixon (2PD) images.](pone.0231156.g003){#pone.0231156.g003}

The limits of agreement in the differences between T1W and 2PD vs. the mean of the two measurements were between 1.96 SD and −1.96 SD.

Mean value, \-\-\-\-\-- 95% limits of agreement. Y = 0 is a line of perfect average agreement.

Thus, we next investigated why there were such differences in IntraMAT content between the two methods for different muscles. [Fig 4](#pone.0231156.g004){ref-type="fig"} compares a representative T1W image, its respective binary image, and the fat image from 2PD for three subjects with relatively higher, middle, and lower IntraMAT contents. Comparing the arrow portions of the T1W image with the binary image and the 2PD fat image, it is clear that the portions of adipose tissue do not coincide. This tendency was observed particularly in subjects with high IntraMAT in T1W images (Figs [4](#pone.0231156.g004){ref-type="fig"} and [5](#pone.0231156.g005){ref-type="fig"}). Moreover, in subjects with a large difference in IntraMAT content between T1W and 2PD, we found a difference in the thresholds in T1W and boundary values of the muscle and adipose tissue when applying the 2PD IntraMAT content to the T1W image ([Fig 5](#pone.0231156.g005){ref-type="fig"}).

![Representative T1-Weighted (T1W) images and fat images by 2-Point Dixon (2PD) of the Biceps Femoris-Long head (BF-L).\
Normal: T1W image after optimized image correction parameters (N3). Binary image: T1W image binarized with threshold value. Upper: subject with high IntraMAT content = 40.1% (T1W), 15.0% (2PD); Middle: subject with moderate IntraMAT content = 20.4% (T1W), 17.7% (2PD); Lower: subject with low IntraMAT content = 6.5% (T1W), 7.1% (2PD).](pone.0231156.g004){#pone.0231156.g004}

![Representative histograms for the Vastus Lateralis (VL) and Biceps Femoris-Long head (BF-L), created based on T1-Weighted (T1W) images.\
T1W threshold: Threshold value of muscle and adipose tissues on T1W images. 2PD boundary value: Boundary value of muscle and adipose tissues with 2PD.](pone.0231156.g005){#pone.0231156.g005}

Finally, we selected 10 subjects at random (five young subjects and five older subjects) and calculated the difference in the threshold in T1W and boundary values for muscle and adipose tissue and the values after applying the IntraMAT content of the 2PD to the T1W image for those subjects. Interestingly, there was a high negative correlation between these two values for the different muscles (VL; r = -0.874, *P* \< 0.01, BF-L; r = -0.944, *P* \< 0.01, VL + BF-L; r = -0.955, *P* \< 0.01; [Fig 6](#pone.0231156.g006){ref-type="fig"}). This result indicates that the difference in IntraMAT content between T1W and 2PD methods depends on the threshold setting.

![Correlation for intramuscular adipose tissue content (IntraMAT content; %) between T1-Weighted (T1W) and 2-Point Dixon (2PD) images, and differences in the 2PD boundary value and T1W threshold for the Vastus Lateralis (VL) and the Biceps Femoris-Long head (BF-L).](pone.0231156.g006){#pone.0231156.g006}

Difference in IntraMAT content (%) = 2PD's IntraMAT content − T1W's IntraMAT content. Difference in signal intensity (AU): Threshold of muscle and adipose tissue on T1W images − boundary value of muscle and adipose tissue when applying 2PD IntraMAT content to T1W images.

Discussion {#sec016}
==========

The main findings of this study were that: 1) IntraMAT content was significantly higher in T1W images than in 2PD images for the AM and the BF-L, but not the VL; and 2) systematic errors were found between T1W and 2PD imaging techniques that can be explained by variations in the threshold setting.

Many attempts have been made to calculate adipose tissue content within soft tissues, such as skeletal muscle, heart, and liver, using the Dixon method in healthy subjects and those with diseases \[[@pone.0231156.ref022], [@pone.0231156.ref030]--[@pone.0231156.ref033]\]. Previous studies have reported that IntraMAT content of the VL by the Dixon method ranged from 3.0 to 3.2% in younger subjects \[[@pone.0231156.ref022], [@pone.0231156.ref030]\]. However, in the present study, the IntraMAT content by 2PD for young subjects was 10.9 ± 1.2% in the VL, which was three times higher than that found in previous studies. Imaging methods (2PD or 3PD), differences in volume and cross-sectional area, subject characteristics or physical activity levels could all explain these differences in IntraMAT values.

In the present study, the IntraMAT content by T1W was two times higher than that found in previous studies \[[@pone.0231156.ref013]--[@pone.0231156.ref015]\]. A previous study reported that IntraMAT contents of the VL were 3.6% and 7.7% in younger and older subjects, respectively, who were men and women \[[@pone.0231156.ref014]\]. Subject characteristics, physical activity levels, and sex differences could all explain these differences in IntraMAT values. We showed that IntraMAT content in the VL and BF-L were 7% and 19%, respectively, in the older group, and 3% and 13%, respectively, in the younger group. The IntraMAT in the BF-L was thus 3- to 4-fold higher than that in the VL \[[@pone.0231156.ref014]\]. Overend and colleagues \[[@pone.0231156.ref034]\], who used computed tomography (CT) imaging for relatively non-contractile tissue (i.e., IntraMAT and connective tissues) within the quadriceps and hamstring muscle groups, found that IntraMAT was 3.6% and 5.4%, respectively, in younger subjects, and 7.7% and 13.6%, respectively, in older subjects. This difference in content aligns with our findings, and thus, it is a reasonable finding that the levels of adipose tissue within the VL were less than that in the BF-L. We also previously measured intramyocellular lipids (IMCL) and extramyocellular lipids (EMCL) using ^1^H magnetic resonance spectroscopy (^1^H-MRS) in male and female subjects across a broad age range, and found collective lipid levels ranging from 9.4 to 40.2 mmol/kg wet weight, respectively, in the VL and from 10.5 to 94.0 mmol/kg wet weight, respectively, in the BF-L \[[@pone.0231156.ref013]\]. Accordingly, it is plausible that IntraMAT in the VL is likely to be lower than that in the BF-L on various imaging modalities, including MRI, CT, and ^1^H-MRS.

Although IntraMAT content in the AM and BF-L by T1W were significantly higher (by 3.0% and 8.7%, respectively) than that found by 2PD ([Table 1](#pone.0231156.t001){ref-type="table"}), there was no difference in IntraMAT content for VL between the two methods, suggesting that the absolute conformity of the IntraMAT content was muscle-specific ([Table 1](#pone.0231156.t001){ref-type="table"}). Thus, particular attention must be paid to the differences noted for AM and BF-L between the two methods. As shown in [Fig 5](#pone.0231156.g005){ref-type="fig"}, T1W and threshold-adjusted T1W images gave the same IntraMAT values as that found with 2PD; i.e., 2PD boundary value, located at the right edge of the muscle peak in the VL, indicated that almost all of the ROI was skeletal muscle using this thresholding technique. The 2PD threshold was higher than that for T1W, and this may have led to false results in terms of the amount of adipose tissue in the AM and BF-L, even though the area was categorized as skeletal muscle tissue. As a result, IntraMAT content determined by T1W was significantly higher than that determined by 2PD in the AM and BF-L.

The further assessments conducted in [Fig 6](#pone.0231156.g006){ref-type="fig"} show that the difference in IntraMAT content determined by T1W and 2PD was almost perfectly associated with differences in threshold values in randomly selected subjects; i.e. differences were dependent on signal intensity. This result suggests that the difference in IntraMAT by T1W and 2PD was closely related but dependent on threshold settings. This would be the main reason for the systematic errors in the Bland-Altman analysis of VL, BF-L and AM shown in [Fig 3](#pone.0231156.g003){ref-type="fig"}.

Inhomogeneity of the magnetic field in the MR system may also affect IntraMAT content values for AM and BF-L. Indeed, a previous study reported that the magnetic field on T1W images was not constant, with correction necessary to rectify for such inhomogeneity effects \[[@pone.0231156.ref014], [@pone.0231156.ref026]\]. We used the well-established N3 algorithm to correct for shading in the images due to heterogeneity linked to suboptimal radiofrequency coil uniformity or gradient-driven eddy currents \[[@pone.0231156.ref014], [@pone.0231156.ref026]\]. Although we confirm that shading was much decreased compared with the original MR image, there is still some shading evident (e.g., from anterior to posterior or medial to lateral) \[[@pone.0231156.ref012], [@pone.0231156.ref014]\]. We expect that these persistent shading defects may have influenced our IntraMAT values. In addition, we considered that the location of muscles and imaging methods could be related changes in the signal-to-noise ratio (SNR). We measured SNR with the subtraction method, which is the most commonly used method \[[@pone.0231156.ref035]\]. In this method, a difference image was obtained by subtracting two identical images. We measured the SNR between T1W and water images, and T1W and fat images for 10 subjects, in the same size ROI of four corners (ROI 1 to ROI 4) to compare the SNR between the ROIs. The SNR in ROI 4 was a significantly higher than in ROI 1, but there was no significant difference between the other ROIs ([Fig 7A and 7B](#pone.0231156.g007){ref-type="fig"}). In this study, VL was on the ROI 3 side, AM was on the ROI 2 side, and BF-L was on the ROI 4 side. These results suggest that the effect of SNR was not observed independent of the location of muscles in this study. Unfortunately, we could not use the same voxel size between the T1W and 2PD imaging methods because of the MR device; therefore, the effect of the SNR on the results of IntraMAT could not be excluded. Furthermore, the effect of local distortion in the MR by distance of the center of the gantry to the body coil and the measurement site could also be related to the difference in IntraMAT content between T1W and 2PD. Thus, this study had some important limitations. Further human and phantom experiments under stable conditions of voxel size, SNR, and specific absorption rate would be required to reveal what caused the difference in IntraMAT content between T1W and 2PD.

![Difference of four corners in the signal-to-noise ratio (SNR) between T1-Weighted (T1W) and water images, and T1W and fat images.\
\**P* \< 0.05, vs. regions of interest (ROI) 1.](pone.0231156.g007){#pone.0231156.g007}

Importantly, T1W has been used to measure IntraMAT in previous studies \[[@pone.0231156.ref003], [@pone.0231156.ref005], [@pone.0231156.ref008], [@pone.0231156.ref010], [@pone.0231156.ref012]--[@pone.0231156.ref016], [@pone.0231156.ref023]--[@pone.0231156.ref025]\], with a close relationship between IntraMAT content by T1W and histochemical analysis of muscle biopsies \[[@pone.0231156.ref021]\]. Furthermore, T1W can be used in any MRI systems from lower to higher magnetic fields. However, the Dixon method is recommended for MRI with a 1.5T or higher because of its technical limitations in being able to clearly distinguish between water and fat signals. IntraMAT content by both T1W and 2PD methods was consistent or correlated with muscle biopsy in previous studies, However, when T1W imaging is used, extra care must be taken of the IntraMAT content discrepancy with 2PD found in this study.

The discrepancy in IntraMAT contents of the T1W and 2PD methods is unknown in this study. We previously showed that IntraMAT content by T1W primarily represents EMCL, not IMCL, in the VL and BF-L muscles \[[@pone.0231156.ref013]\]. On one hand, this could be because a relatively 5 to 10 times larger amount of lipids accumulates in the interstitium compared with the cytoplasm of the muscle cells \[[@pone.0231156.ref013]\]. On the other hand, Fischer et al. (2014) reported that IntraMAT content by 2PD was closely related with the sum of IMCL and EMCL contents detected by ^1^H-MRS (r = 0.918 to 0.990, *P* \< 0.001) \[[@pone.0231156.ref036]\]. However, it has not been established that IntraMAT contents by both T1W and 2PD methods reflected EMCL only, as shown by Akima et al. \[[@pone.0231156.ref013]\], or IMCL and EMCL, as shown in Fischer et al. \[[@pone.0231156.ref036]\] using ^1^H-MRS. The major limitation in the present study was that we did not directly compare biopsy or ^1^H-MRS results with MR images (T1W and 2PD), and we did not detect the exact changes in fat content (IMCL and EMCL) or total adipose tissue content. Therefore, it is important that additional research is carried out to confirm the validity of segmentation analyses for T1W and 2PD images by combining IMCL and EMCL data with ^1^H-MRS or histochemical analysis.

Conclusions {#sec017}
===========

Although there was no significant difference between T1W and 2PD in IntraMAT content for the VL, the IntraMAT content using T1W was significantly higher in the AM and BF-L as compared with the 2PD method. We suggest that this is primarily because of differences in threshold settings when using T1W, particularly for measurements of the BF-L. Thus, these results suggest that care should be taken when selecting an imaging modality for IntraMAT, especially for patients who would be suspected of having higher IntraMAT values.
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Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Dec 29 2019 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Kiyoshi Sanada, PhD

Academic Editor

PLOS ONE

Journal Requirements:

1\. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified who gave consent and whether it was informed.

3\. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see <http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions>.

In your revised cover letter, please address the following prompts:

a\) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b\) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see <http://www.bmj.com/content/340/bmj.c181.long> for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see <http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories>.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4\. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: In this manuscript, the author aimed to compare intramuscular adipose tissue content determined by two-point Dixon imaging and T1-weighted imaging, calculated using thresholding techniques. This study showed that there was no significant difference between T1W and 2PD in IntraMAT content for the VL, whereas the IntraMAT content using T1W was significantly higher in the AM and BF-L as compared with the 2PD method. Additionally, this is primarily because of differences in threshold settings when using T1W. This manuscript may be potentially interesting and clinical significance, however, there are several key concerns that need to be addressed.

Major comments:

1\. The authors concluded that T1W imaging is likely to be the better option for IntraMAT measurements. It is ambiguous about the process of this conclusion. Therefore, the authors need to discuss the more clearly. IntraMAT content determined by T1W was significantly higher than that determined by 2PD in the AM and BF-L. Which value is appropriate?

2\. What is the gold standard to assess IntraMAT? T1W? Dixon? biopsies? Please describe in the introduction.

3\. Is the order of measurement randomized? Can the authors clarify the study protocols?

4\. In the Table 1, the authors should present the comparison between young and older. It will be interesting to know whether the effects of aging differ between T1W and 2PD methods.

5\. Instead of showing only the relationship between difference in IntraMAT contents and difference in signal intensity, Figure should present the relationship between IntraMAT content determined by T1W and 2PD

6\. In the Figure 3, is there the representative image of Lower IntraMAT?

7\. the authors described "the IntraMAT content of this study by 2PD which was three times higher than that found in previous studies". How is T1W compared to previous studies? Please discuss.

Minor comments:

1\. Please change "positive correlation" to "negative correlation" (page 14, line 7).

Reviewer \#2: The paper brings some original data and I have read it with a great interest. Nevertheless I have few comments and suggestions:

The MR image shows a change in contrast when there is a distance change from the magnetic field center in the gantry.

Therefore, in addition to this experimental data, 1) Change the subject\'s imaging position, 2) After imaging at a site away from the center of the bore, recalculate to see if similar results are obtained.

In addition, the calculated MR signal intensity depends on the voxel size. Therefore, change the Voxel size and verify that similar results are obtained.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0231156.r002

Author response to Decision Letter 0

5 Jan 2020

Journal Requirements:

Q1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

A1. I confirmed PLOS ONE style templates and changed our maniscript.

Q2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified who gave consent and whether it was informed.

A2.I added Ethics Statement in online and manuscript. However, if you need to more information, please tell me.

Q3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see <http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions>.

In your revised cover letter, please address the following prompts:

a\) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b\) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see <http://www.bmj.com/content/340/bmj.c181.long> for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see <http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories>.

We will update your Data Availability statement on your behalf to reflect the information you provide.

A3.Our data contain potentially identifying information and ethics committee didn\'t allow the connecting internet those data. Data are available from Ethics Committee for researchers who meet the criteria for access to confidential data.

Ethics committee of Nagoya University Graduate School of Medicine

Address: Nagoya University 65 Tsurumai, Showa-ku, Nagoya, Aichi 466-8550, Japan

E-mail: <ethics@med.nagoya-u.ac.jp>

Q4. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical.

A4. We apologize for this oversight. We confirmed and changed our abstract in manuscript and online.

Q5. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript.

A5. We deleted ethics statement in end of our manuscript. We written ethics statement in Methods.

###### 

Submitted filename: Response to Reviewers.docx

###### 

Click here for additional data file.

10.1371/journal.pone.0231156.r003
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Comparing intramuscular adipose tissue on T1-weighted and two-point Dixon images

PLOS ONE

Dear Dr. Ogawa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Mar 14 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Kiyoshi Sanada, PhD

Academic Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The authors have addressed my major concerns, and the manuscript has much improved. I have no further comments for the authors.

Reviewer \#2: I understand your response.

It can be inferred from the text that T1w and the 2PD method was performed continuously. Since it is described as \"consective,\" it is not necessary to describe it as \"continuously.\"

As you know and use it, MR devices have different image data and contrast (power from changes in SN and SAR) depending on continuous imaging and shimming conditions. These problems have been corrected in the image conversion process. If it is far from the center of the gantry, the effect of local distortion, due to MR, also appears.

It is not a matter of continuity, but the MR system. In addition, the distance between the body-coil and the measurement site is also an issue.

This paper is a valuable paper that utilizes an uncomplicated evaluation and hopes for future development. Therefore, it is essential that the reliability of the published data is established and whether the reader can obtain comparative data by the same method. I understand your response is giving up its verification.

The previous advice does not consider continuous imaging as a problem but points out the reproducibility of data. I highly recommend you to describe problems with MR equipment properly. The advice for voxel size is the same.

These points should also be considered in the limitations.

If you use a method that can be evaluated easily, it is recommended that you consider it properly.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0231156.r004

Author response to Decision Letter 1

11 Mar 2020

Dear Dr. Sanada and Reviewer \#2

We wish to express our deep appreciation to the reviewer for the insightful comment on our manuscript. We apologize for not answering your previous question perfectly.

We have worked hard to incorporate your feedback and hope you will agree that that these revisions have made our manuscript suitable for publication in PLOS ONE.

Sincerely,

Madoka
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Submitted filename: Response to Reviewers0310.docx

###### 

Click here for additional data file.
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18 Mar 2020

Comparing intramuscular adipose tissue on T1-weighted and two-point Dixon images

PONE-D-19-29508R2

Dear Dr. Ogawa,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Kiyoshi Sanada, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: (No Response)

Reviewer \#2: I have no further comments for the authors.

I read the revised version. Although the experimental data can be easily measured by using the MR device, the verification of the data becomes uncertain if the experiment is performed without understanding its essence. I think the paper is more polite than the previous one.

I am looking forward to reading your future paper.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

10.1371/journal.pone.0231156.r006
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23 Mar 2020

PONE-D-19-29508R2

Comparing intramuscular adipose tissue on T1-weighted and two-point Dixon images

Dear Dr. Ogawa:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Kiyoshi Sanada

Academic Editor

PLOS ONE

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: Current address: Nippon Sport Science University, Setagaya-ku, Tokyo, Japan
